Lung and heart-lung transplantation: Overview of results

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Graft Rejection 100%
• Infection 50%
• Survival Rate 50%
• Overall Survival 50%
• Prevalence 50%
• Immunosuppressive Agent 50%
• Chronic Obstructive Lung Disease 50%
• Pulmonary Hypertension 50%
• Cystic Fibrosis 50%
• Alpha Antitrypsin Deficiency 50%
• Fibrosing Alveolitis 50%
• Emphysema 50%
• Eisenmenger Complex 50%

Keyphrases

• Lung 100%
• Lung Transplantation 100%
• Heart-lung Transplantation 100%
• United States 33%
• Acute Rejection 33%
• Pretransplant 16%
• Overall Survival 16%
• 5-year Survival 16%
• Chronic Infection 16%
• High Prevalence 16%
• Alpha-1 Antitrypsin Deficiency 16%
• Chronic Obstructive Pulmonary Disease 16%
• Quality of Life 16%
• Cystic Fibrosis 16%
• Donor Organs 16%
• Emphysema 16%
• 3-year Survival 16%
• Immunosuppressive Regimens 16%
• Idiopathic Pulmonary Fibrosis 16%
• Eisenmenger Syndrome 16%
• Waiting Time 16%
• Primary Pulmonary Hypertension 16%
• Pulmonary Hypertension Syndrome 16%

Medicine and Dentistry

• Lung Transplantation 100%
• Heart Lung Transplantation 100%
• Lung 100%
• Chronic Graft Rejection 33%
• Prevalence 16%
• Infection 16%
• Survival Rate 16%
• Transplantation 16%
• Overall Survival 16%
• Immunosuppressive Drug 16%
• Pulmonary Hypertension 16%
• Chronic Obstructive Pulmonary Disease 16%
• Quality of Life 16%
• Cystic Fibrosis 16%
• Alpha Antitrypsin Deficiency 16%
• Organ Donor 16%
• Emphysema 16%
• Eisenmenger's Syndrome 16%
• Idiopathic Pulmonary Fibrosis 16%